Cosmetic
Use of Octyl—2—Cyanoacrylate for Skin, Closure
in Facial Plastic Surgery
Dean M. Toriumi, M.D., Kevin O’Grady, Devang Desai, M.D., and Amita Bagal, M.D.
Chicago, Ill.
Octyl—2-cyanoacrylate is a long carbon chain cyanoac-
rylate derivative that is stronger and more pliable than its
shorter chain derivatives. One hundred and eleven pa— ‘
tients underwent elective surgical procedures by the same
surgeon using either octyl-2—cyanoacry1ate or sutures for
skin closure at the University of Illinois at Chicago. Most
patients underwent excision of benign skin lesions with a
mean wound size of 112 mIn3. Patients were randomized
into either control (vertical mattress suture closure) or
test groups (closure with octyl—2-cyanoacrylate). Surgical
judgment was used to determine which wounds in each
group required application of subcutaneous sutures to .
relieve tension and aid in skin edge eversion. Generally,
full-thickness (through dermis) wounds larger than 1 cm3
required the use of subcutaneous sutures. The time re-
quired to close the epidermis with suture (mean, 3 min-
utes and 47 seconds) was about four times that of octyl-
2—cyanoacrylate (mean, 55 seconds). Wounds were
evaluated at 5 to 7 days for infection, wound dehiscence,
or tissue reaction, and at 90 days using the modified Hol-
lander wound evaluation scale. At 1 year, photographs of
the wounds were evaluated by two facial plastic surgeons
that graded the cosmetic outcome using a previously,val—
idated visual analog scale.
There were no instances of wound dehiscence, hema-
toma, or infection in either group. Results of wound eval-
uation at 90 days determined by the modified Hollander
scale revealed equivalent cosmetic results in both groups.
Results of the visual analog scale ratings showed scores of
21.7 i 16.3 for the 49 patients treated with octyl-2—cya—
noacrylate and 29.2 : 17.7 for the 51 control patients
treated with sutures. The lower visual analog scale score
represented a superior cosmetic outcome at 1 year with
the octyl—2-cyanoacrylate as compared with sutures. This
difference is statistically significant at p = 0.03. Addition-
ally, patient satisfaction was very high in the group treated
with octyl—2-cyanoacrylate. (Plast. Reconstr. Surg. 102:
2209, 1998.)
Precise approximation of skin incisions and
lacerations with wound closure devices is criti-
cal to a favorable cosmetic and functional sur-
gical result. Principles of wound closure focus
on relieving tension on the wound and bring-
ing the skin edges together in an everted ori-
entation.” Application of sutures requires pas-
sage of a foreignmaterial through the skin that
is usually left in place for 5 to 10 days. If sutures
are tied too tight or left in. too long, they may
leave permanent suture tracks.3 If sutures are
removedbefore adequate healing, the lack of
wound tensile strength may result in wound
dehiscence or a widened scar. Although suture
removal usually causes minimal discomfort, the
procedure is often associated with increased
patient anxiety. Additionally, suture removal in
sensitive areas of the face, such as the nose,
eyelids, and lips, can result in significant dis-
comfort. New technology in surgical adhesives
may provide the option of sutureless skin clo-
sure.
The ideal adhesive would: (1) be safe for
topical application, (2) be easy to apply, (3)
polymerize rapidly, (4) support the approxi-
mated skin edges and maintain the skin edge
eversion necessary for maximum wound heal-
ing and acceptable cosmesis, and (5) eliminate
the need for suture removal. The development
of such technology, although useful for a vari-
ety of surgical applications, including plastic
surgery, would be of particular benefit in the
treatment and follow—up care of pediatric pa-
tients.“’5
Over the years, cyanoacrylates have been
used for skin closure,“‘7 fixation of implants,“
tissue adhesion,4’5’8 closure of cerebrospinal
From the Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology—Head and Neck Surgery, University of Illinois
at Chicago. Received for publication February 23, 1998; revised May 11, 1998.
Presented in part at the Annual Fall Meeting of the American Academy ofFacial Plastic and Reconstructive Surgery, San Francisco, California,
September 4, 1997.
2210
fluid leaksf’ and embolization of blood ves-
sels.” In Europe and Canada, cyanoacrylate
derivatives have been available as a surgical
tissue adhesive for many years.5“7 Despite their
availability, cyanoacrylate adhesives have failed
to gain widespread popularity due, in part, to
their suboptimal handling and application
characteristics, variable outcomes, and the his-
totoxicity associated with their use.”'13 The his-
totoxicity associated with these materials is re-
lated to the by-products of polymer
degradation, length of the alkyl (R) group of
the cyanoacrylate derivative, and the rate at
which degradation occurs.“‘13 Degradation of
the cyanoacrylate polymer yields the histotoxic
by-products cyanoacetate and formalde-
hyde.“'13 The shorter chain methyl—2—cyanoac-
rylate and ethyl-2-cyanoacrylate derivatives de-
grade at a faster rate than their longer chain
counterparts, resulting in significant tissue tox-
icity.“ Butyl—2-cyanoacrylate (Histoacryl,
Braun, Germany), which has"/a four-carbon al-
kyl constituent off the carboxyl group (COO-
R), is approved for use in ,.Europe and Canada
and is less toxic than methyl—2—cyanoacrylate
and ethyl-2-cyanoacrylate because of its slower
rate of degradation.”
Octyl-2—cyanoacrylate (Dermabond, Ethicon
Inc., Somerville, NJ.) was formulated to cor-
rect some of the deficiencies of the shorter
chain cyanoacrylate derivatives. As an eight-
carbon alkyl derivative, the polymer should be
less reactive than the shorter chain deriva-
tives.“~13 The slower degradation of the octyl
derivative may decrease the concentration of
cyanoacrylate polymer by—products in sur-
rounding tissues, resulting in less inflamma-
tion. Additionally, plasticizers are used to pro-
duce a stronger, more pliable, tissue-
compatible end product that will flex with the
skin and remain adherent for longer periods of
time. Octyl-2—cyanoacrylate has a three-dimen-
sional breaking strength that is three times that
of butyl-2-cyanoacrylate.”
Two recently published clinical studies ex-
amined the external use of octyl-2—cyanoacry—
late adhesive for superficial skin closure.15’16
Results of these studies showed no statistically
significant difference in wound cosmesis be-
tween wounds treated with octyl-2—cyanoacry-
late and sutures.15=15 In our study, a prospective,
randomized, controlled clinical trial was per-
formed to determine if Octyl-2—cyanoacrylate is
equivalent to standard suture skin closure. This
study was performed as one arm of a multi-
PLASTIC AND RECONSTRUCTIVE SURGERY, November 1998
institutional study with other centers in emer-
gency medicine/ emergent care, dermatology,
general surgery (hernia repair), obstetrics and
gynecology (laparoscopic surgery), and ortho-
pedic surgery. The University of Illinois at Chi-
cago was the only facial plastic surgery center
in the study. This study differs from the two
previously published clinical studies on octyl-2-
cyanoacrylate in that the same surgeon (DMT)
performed all surgeries and long—term, 1-year
follow-up photographs were obtained and an-
alyzed to assess the final cosmetic outcomes.
MATERIALS AND METHODS
One hundred and eleven patients were ‘en-
rolled and treated in an office minor surgical
setting in facial plastic and reconstructive sur-
gery according -to the guidelines of the Institu-
tional Review Board of the University of Illinois
at Chicago. Before study inclusion, a medical
history and a review of recent and concomitant
medications were performed. Patients were
then evaluated on the basis of predetermined
inclusion and exclusion criteria (Tables I and
II‘). Those who successfully met and agreed to
the study criteria and who read and signed the
informed consent form were enrolled in the
study.
Using clinical indications as evaluated by the
surgeon, patients were assigned to one of two
treatment groups: (1) wounds with subcutane-
ous sutures or (2) wounds without subcutane-
ous sutures (Fig. 1). The primary criteria used
to determine the need for subcutaneous su-
tures are listed in Table III. Where appropri-
ate, subcutaneous sutures (4-0 or 5-0 Polydiox-
anone, Ethicon) were applied to aid in
apposition of the wound edge margins, relieve
tension, ensure adequate skin edge eversion,
and prevent deposition of Octyl-2—cyanoacrylate
TABLE I
Enrollment Criteria
Inclusion Criteria Exclusion Criteria
Patients must: Patients presenting with:
1. Be at least 1 year of age 1. Significant multiple trauma
2. Be in good general health 2. Peripheral vascular disease
with no significant systemic 3. Insulin—dependent diabetes
abnormalities mellitus
3. Agree to return for follow-up 4. Blood clotting disorder
visits 5. Personal or family history
of keloid or hypertrophic
scar formation
6. Known allergy to
cyanoacrylate or
formaldehyde
Vol. 102, No. 6 / OCTYL—2-CYANOACRYLATE FOR SKIN CLOSURE A 2211
TABLE II
Specific Wounds Excluded from the Study
. Decubitus ulcers
. Stellate lacerations
Wounds on hair-bearing skin
. Wounds from an animal or human bite
Wounds with evidence of infection or rash
. Wounds on mucosa or at mucocutaneous junctions
. Wounds usually closed with 4-0 caliber suture or larger
. Puncture wounds (other than punctures initiated from
minimally invasive surgical procedures)
ooxrmfitniapaww
Patient Presen ts
Patientliligible ‘ No———— Out
Yes
WounclEligib|e ‘ No-—-— Out
Yes
Physician Discretion
No Subcutaneous Sutures 1
* L_.______/
Sutures octyl} i Sutures
J Cy““°l‘“ V M J
FIG. 1. Algorithm showing the method of randomizing
patients into test and control groups.
into the wound (Fig. 2, above). In some cases,
wounds that could not be easily closed with
5-0—caliber skin sutures. were approximated
with subcutaneous sutures to allow closure with
5-O—caliber (or smaller) sutures or octyl-2-
cyanoacrylate. Subcutaneous sutures were
rarely used in cases with partial-thickness
wounds not penetrating through the dermis
(Fig. 2, center and below). After appropriate as-
signment, patients were randomized for skin
closure into either the test group (octyl-2-
cyanoacrylate) or the control group (sutures).
Before surgical intervention, surgical sites
were cleansed with an antiseptic agent and
injected with local anesthesia (1% lidocaine
TABLE III
Criteria for Use of Subcutaneous Sutures
Subcutaneous sutures are recommended for use when:
1. Subcutaneous dead space exists
2. The wound tendency is toward skin edge inversion
3. The wound is greater than 1 cm in length and/or greater
than 1 cm in width
4. Tension on skin edges may prohibit easy closure with a
5-0 caliber suture
5. The depth of wound is beyond the depth of dermis (full-
thickness) unless skin is thin (eyelid skin)
with 1:l00,()00 epinephrine), The borders of
the surgical site were marked with a marking
pen, incisions were made, and the surgical de-
fect was created (Fig. 3, above, left). Hemostasis
was attained either by applying pressure or by
using electrocauterization. Skin closure was
performed based on patient randomization.
Patients randomized to the control group, ei-
ther with or without subcutaneous sutures, un-
derwent vertical mattress skin closure with 5-0
or 6-0 nylon suture, whereas test patients, ei-
ther with or without subcutaneous sutures, un-
derwent skin closure using octyl-2-cyanoacry-
late. In the test group without subcutaneous
sutures, forceps were used to maintain skin
edge eversion during application of the adhe-
sive (Fig. 2, center, right).
The adhesive was packaged in a sterile dis-
posable blister pack that allowed easy applica-
tion through a permeable tip after breaking
th-einternal capsule containing the monomer.
The adhesive was applied in multiple thin lay-
ers over the incision site_._, v\n'th a 10- to 30-
second delay between applications, to prevent
pooling or running. Initial application of a
thin layer of adhesive acted as a barrier, which
minimized any heat dissipation to the tissues
while polymerization, occurred. The adhesive
was applied .n and around the incision, ex-
tending,,5t/0010' mm beyond the incision, to
ensure tissue stability (Fig. 3, above, right). Once
completed, incision sites of the control pa-
tients were treated with antibiotic ointment
and covered with a bandage. Patients in the
test group did not require an external bandage
as the adhesive formed its own protective cov-
ering (Fig. 3, below, left).
The time required for epidermal skin clo-
sure was recorded for both the test and control
groups and only included the time required to
apply the skin closure device (skin sutures or
octyl-2-cyanoacrylate). This time did not in-
clude application of the anesthesia, excision of
the lesion, hemostasis or, where appropriate,
application of the subcutaneous sutures be-
cause these segments of the operations were
independent of the method of epidermal skin
closure.
Patients in the control group were instructed
to keep their wounds clean and dry before
suture removal. Test patients were allowed to
get their wounds wet, but they were asked to
avoid soaking or scrubbing the surgical site.
Patients were further instructed to allow the
polymer to slough off from the wound site
2212
PLASTIC AND RECONSTRUCTIVE SURGERY, November 1998
FIG. 2. (Above, left) Everting subcutaneous suture used to take all tension off skin edges and
evert wound after full-thickness incision through dermis. Note how the sutures are applied on
the undersurface of the undermined dermal layer to obliterate all subcutaneous dead space and
maximize eversion of the skin edges. (Above, right) Precise apposition of skin edges prevents
subcutaneous deposition of octyl-2-cyanoacrylate. (Center, left) Partial-thickness skin incision or
laceration with limited penetration of the dermal layer. Subcutaneous sutures are usually not
necessary because there is limited separation of the dermis or subcutaneous tissues. (Center, right)
Soft tissue forceps can be used to evert the skin edges while applying octyl-2-cyanoacrylate. (Below)
Note how skin edge eversion can be achieved using octyl-2—cyanoacrylate without subcutaneous
sutures.
without assistance. Patients who received su-
tures underwent suture removal at 5 to 7 days
postoperatively. At each postoperative visit,
wounds were examined for infection, inflam-
mation, wound dehiscence or separation, and
scarring.
At the 90-day follow—up visit, the wounds
were graded for cosmesis using the modified
Hollander wound evaluation scale, which eval-
uates six clinical categories, including step-off
borders, contour irregularities, scar width,
edge inversion, excessive inflammation, and
overall cosmetic appearance of the wound.”
For each patient, a score of 0 or 1 was assigned
for each category. The six categories were then
added together and a total score was recorded.
A score of 0 reflected an optimal cosmetic
outcome, whereas a score of 1 to 6 reflected a
suboptimal cosmetic outcome. Wound evalua-
tion scores of both the test and control groups
were then compared to determine if any signif-
icant difference was evident between wounds
closed with sutures versus wounds closed with
octyl-2—cyanoacrylate.
A final long-term follow-up visit, at approxi-
mately 1 year posttreatment, was also con-
ducted. This additional long-term follow-up
visit, which was not part of the multicenter
or
V0
2213
Vol. 102, No. 6 / ocm.-2—(:\ANoAcRY1A'rE FOR SKIN CLOSURE
Flt}. (Above, lefl) Fusiform 2-cm defect created after excising facial lesion. (Above, righl) Application ofoctyl—2-cyanoaciylate
to the opposed, everted skin edges after completion of subcutaneous closure. Multiple thin layers are applied, and the adhesive
extends 5 to 10 mm beyon(l the incision to provide support. (Below, left) Octyl—2—cyanoac1ylate closure at end ofprocedure. Note
that the polymer is clear and the wound can be visualized to assess for dehiscence or infection. (Below, right) One-year
postoperative photograph ofsurgical scar after excision of benign skin lesion and closure with octyl-2-cyanoacrylate. Arrows point
[0 SCAII
Vol. 102, No. 6 / OCTYL—2-CYANOACRYLATE FOR SKIN CLOSURE ‘ 2213
FIG. 3. (Above, lefi) Fusiform 2-cm defect created after excising facial lesion. (Above, right) Application of octyl-2—cyanoacrylate
to the opposed, everted skin edges after completion of subcutaneous closure. Multiple thin layers are applied, and the adhesive
extends 5 to 10 mm beyond the incision to provide support. (Below, left) Octyl-2—cyanoacrylate closure at end of procedure. Note
that the polymer is clear and the wound can be visualized to assess for dehiscence or infection. (Below, right) One—year
postoperative photograph of surgical scar after excision of benign skin lesion and closure with octyl-2-cyanoacrylate. Arrows point
to scar.
2214
protocol, required contacting all of the study
participants by telephone or letter to schedule
standardized studio photographs. A Nikon F3
camera body (Nikon, Tokyo, Japan) with a
105—mm lens and point flash was used for all
photographs. The photographs were taken
with 35-mm ASA 100 Ektachrome film (Kodak,
Rochester, N.Y.) and were shot at a 1:1 and 1:2
magnification to provide good discrimination
of the treatment site.
The photographs were then given to two
facial plastic surgeons that were unfamiliar
with the study design, the purpose or site of the
surgical incision, or the type of treatment re-
ceived (sutures versus octyl-2-cyanoacrylate).
Each surgeon was asked to rate the cosmetic
results of the surgical sites using a visual analog
scale by placing a mark along the scale that
would correspond to the cosmetic out-
come.15'“’V18 The wound cosmesis visual analog
scale was based on a 100—mm line, with the best
possible scar positioned at point 0 on the left
side of the line and the worst possible scar
positioned at the 100-mm point on the right
side of the line. The score was then determined
by measuring the distance in millimeters from
point 0 to the recorded score. The mean score
was determined for each patient to prow'de a
quantitative subjective analysis of each wound.
The wound cosmesis visual analog scale was
used instead of the modified Hollander scale
on the 1-year results to provide a completely
nonbiased analysis by two individuals who spe-
cialized in facial plastic surgery.
Statistical Analysis
The visual analog scale scores for both treat-
ment groups were analyzed using analysis of
variance (BMDP Statistical Software, 1nc., Los
Angeles, Calif.). In a previous study, the
l00—mm visual analog scale was validated.” Sta-
tistical analysis was also performed on the dif-
ferences in treatment time between the
wounds closed with octyl-2-cyanoacrylate and
sutures.
RESULTS
Of the 111 patients enrolled in the study, 57
patients (51.3 percent) were randomized into
the control group, and 54 (48.7 percent) were
randomized into the test group. The mean age
of the patients studied was 41.2 years (range,
11 to 82 years), with no statistically significant
difference in mean age between test and con-
trol groups (test, 40.8 years; control, 41.6
PLASTIC AND RECONSTRUCTIVE SURGERY, November 1998
TABLE IV
Patient Population (11 = 110)
Ethnicity No. of Patients . Patient %
Caucasian 69 62.7
African American 17 15.5
Asian/Pacific Islander 13 11.8
Hispanic 11 10.0
years). Table IV shows the ethnic breakdown of
the patients who were enrolled in the study. In
the control group, 34 patients (59.7 percent)
required subcutaneous sutures, whereas 32 pa-
tients (59.3 percent‘) received subcutaneous su-
tures in the test group. The range in size
(length >< width >< depth) of all wounds
treated was 1 mm?‘ to 1350 mm3, with a mean
wound size of -112 mm3. There was no statisti-
cally significant difference in wound size be-
tween treatment groups. Ninety—six percent of
all procedures were confined to either the face
or the neck, with the majority of patients un-
dergoing excision of skin lesions (66.7 per-
cent) and scar revisions (23.4 percent). After
appropriate treatment, incision sites were
closed according to patient randomization.
The mean time for epidermal skin closure
using suture (control) was 3 minutes and 57
seconds, whereas the mean time for epidermal
skin closure using octyl-2-cyanoacrylate (test)
was 55 seconds (Fig. 4). The total time for
epidermal skin closure for both groups was
225.1 minutes, with 194.55 minutes (86.4 per-
cent) devoted to suture closure of control
wounds and 30.55 minutes (13.6 percent) for
closure of test wounds with octyl-2-cyanoacry-
late. Statistically, this difference in time for skin
closure between octyl-2-cyanoacrylate and su-
tures was significant (p < 0.0001).
Time Required for Epidermal Skin Closure
(Mear1_\_/$3.91- . .
l
i
Octyi-2-cyanoacrylate
i
1
Control (Sutures)
0 50 100 150 200 250
Time in Seconds
FIG. 4. Time required for epidermal skin closure. Com-
parison of time required using sutures (control) versus octyl-
2-cyanoacrylate (test).
-u..-...
Vo.
Fit
thc
Or
in!
ity
aft
pa
ho
lO\
an
er;
ite
are
wi'
tis
wc
an
tic
II]!
de
sit
ra:
of
wt
th
1.-
C3
Cy
Vol. 102, No. 6 / OCTYL-2—CYANOACRYLATE FOR SKIN CLOSURE
Five- to Seven-Day Follow-up
All 111 patients successfully returned for
their 5- to 7-day postoperative follow—up visit.
One control patient presented with a localized
inflammatory reaction resulting from sensitiv-
ity to the antibiotic ointment that was applied
after suture placement. Additionally, one test
patient reported an inflammatory reaction 48
hours posttreatment. However, at_ the early fol-
low—up visit, there was no evidence of infection
and the wound healed without sequelae. Sev-
eral of the wounds closed with sutures exhib-
ited increased inflammation and erythema
around the incision site, whereas those closed
with octyl-2-cyanoacrylate had significantly less
tissue reaction. There were no instances of
wound dehiscence, hematoma, or infection,
and both groups exhibited good approxima-
tion of the skin edges. Sloughing of the poly-
mer was observed to varying degrees depen-
dent on the size of thevwound and anatomic
site. Whereas the majority of small wounds
ranged from 25 percent to complete sloughing
of the polymer at the 5- to 7-day visit, larger
wound sites had only minor sloughing along T
the periphery of the applied polymer.
Ninety—Day F ollow—up
Of the 111 patients, 110 returned for their
90-day postoperative visit. Excellent-to—good
cosmetic outcome was noted in all patients
from both groups. There was no evidence of
healing abnormalities in any of the test or con-
trol patients. In the control group, a number of
incisions had visible suture tracks, whereas
wounds in the test group healed without pe-
ripheral scarring or suture marks. There were
similar outcomes between the octyl-2—cyanoac-
rylate group and the suture group on the mod-
ified Hollander wound evaluation scale. At the
90-day follow-up visit, mean wound evaluation
scores were 0.235 for the suture group (con-
trol) and 0.306 for the octyl-2-cyanoacrylate
group (test). Statistically, there was no signifi-
cant difference between wounds treated with
octyl-2—cyanoacrylate or suture as evaluated us-
ing the modified Hollander scale ([3 = 0.51).
One-Year F ollow-up Evaluation
Of the 111 patients enrolled in the study,
100 (90 percent) returned for their long-term,
1-year follow—up wound evaluation. No compli-
cations were noted in either the octyl-2-
cyanoacrylate or the suture group. However,
2215
persistent suture tracks remained evident in
some of the control patients. At 1 year, the
mean visual analog scale cosmetic outcome was
21.7 1“ 16.3 mm versus 29.2: 17.7 mm for the
octyl-2—cyanoacrylate group and suture group,
respectively. The lower score represented an
improved cosmetic outcome for incisions
treated with octyl-2-cyanoacrylate and was sta-
tistically significant at p = 0.03 (Fig. 3, below,
right) .
DISCUSSION
The concept of a surgical tissue adhesive for
superficial skin closure is an attractive alterna-
tive to the use of sutures to both physicians and
patients. Suture placement always requires ap-
plication of an anesthetic agent and takes sig-
nificantly more time than application of octyl-
2-cyanoacrylate. Although placement (under
anesthesia) and removal of sutures rarely
causes pain, a high degree of patient anxiety
associated with these procedures remains. This
is particularly true within the pediatric popula-
tion or when small-caliber sutures must be re-
moved from sensitive areas of the face (nose,
eyelid, lips, etc.). Many children will not permit
the surgeon to remove sutures without being
restrained or sedated. Use of octyl-2-cyanoacry-
late for skin closure significantly decreases the
time of treatment‘ for wound closure and elim-
inates the need for postoperative suture re-
moval. And, although 5- to 7-day follow—up vis-
its may still be necessary, patients will not
experience the anxiety and discomfort often
associated with suture removal. Additional ben-
efits of octyl-2-cyanoacrylate noted during the
study include ease of use; formation of its own
protective barrier, eliminating the need for ad-
ditional bandages; and excellent cosmetic out-
come.
Analysis of the study data revealed that skin
closure with octyl-2-cyanoacrylate provided
equivalent cosmetic results when compared
with sutures as determined by the modified
Hollander wound evaluation scale performed
at the 90-day time point. This scale has less
ability to discern small differences in cosmetic
outcome than the visual analog scale wound
evaluation method. The visual analog scale
scores obtained by analysis of the long-term,
1-year postoperative photographs revealed su-
perior cosmetic results of incisions closed with
octyl-2-cyanoacrylate compared with controls
treated with sutures. The overall excellent cos-
metic results and absence of complications (in-
,, ,,, ,_ m.
2216
fection, dehiscence, etc.) can be attributed, in
part, to the fact that most of the incisions were
clean, incised wounds with appropriate use of
subcutaneous closure. One would expect less
optimal results in traumatic wounds that are
closed without the use of subcutaneous su-
tures.
Before adhesive application, wounds must
be evaluated for placement of subcutaneous
sutures to eliminate subcutaneous dead space,
decrease wound tension, and maximize skin
edge eversion (Fig. 5). Full-thickness wounds
with a high level of underlying muscular activ-
ity (perioral region, forehead, and over the
mandible) or where deep tissues have been
separated through incision or laceration
should be treated with subcutaneous sutures
before skin closure. If the deep tissue layers are
not reapproximated, the dead space resulting
from the lack of subcutaneous tissue approxi-
mation may result in a depressed scar (Fig. 6).
Thinner skin, such as that in the eyelid, con-
tains minimal subcutaneous tissue; therefore,
PLASTIC AND RECONSTRUCTIVE SURGERY, November 1998
subcutaneous sutures are not required before
epidermal skin closure. The determination as
to when subcutaneous sutures should be used
will require physician discretion. In our expe-
rience, subcutaneous sutures should be ap-
plied (l) to all full-thickness wounds requiring
obliteration of subcutaneous dead space, (2) to
alleviate wound tension noted during skin clo-
sure, and (3) to enhance skini edge eversion
where necessary (thicker, less pliable skin, e.g.,
forehead, cheek). Even with proper prepara-
tion and subcutaneous suture placement, con-
ventional suturing methods (vertical mattress
sutures) remain the treatment of choice in
areas where marked wound edge eversion is
desired?
Some surgeons may believe that the applica-
tion of subcutaneous sutures provides ade-
quate skin edge eversion and requires only
adhesive strips for epidermal closure. In our
experience, application of adhesive strips will
tend to decrease the degree of skin edge ever-
sion because of the vertical component of
FIG. 5. (Above, left) Everted skin closure after excision of benign tumor from forehead. (Above, right) Polymerization of
octyl-2-cyanoacrylate leaves a thin layer of polymer on wound. (Below, left) Polymer begins to peel off 7 days after application.
(Below, right) One—year postoperative photograph of healed surgical site with acceptable cosmetic outcome. Arrows point to the
ends of the scar.
V0.
2216
fection, dehiscence, etc.) can be attributed, in
part, to the fact that most of the incisions were
clean, incised wounds with appropriate use of
subcutaneous closure. One would expect less
optimal results in traumatic wounds that are
closed without the use of subcutaneous su-
tures.
Before adhesive application, wounds must
be evaluated for placement of subcutaneous
sutures to eliminate subcutaneous dead space,
decrease wound tension, and maximize skin
edge eversion (Fig. 5). Full-thickness wounds
with a high level of underlying muscular activ-
ity (perioral region, forehead, and over the
mandible) or where deep tissues have been
separated through incision or laceration
should be treated with subcutaneous sutures
before skin closure. If the deep tissue layers are
not reapproximated, the dead space resulting
from the lack of subcutaneous tissue approxi-
mation may result in a depressed scar (Fig. 6).
Thinner skin, such as that in the eyelid, con-
tains minimal subcutaneous tissue; therefore,
FIG. 5. (Above, left) Everted skin closure after excision of benign tumor from forehead. (Above, right) Polymerization of
PL.»'\STI('I AND RE(j()NSTRUCT1\/I-L SURGERY, November 1998
subcutaneous sutures are not required before
epidermal skin closure. The determination as
to when subcutaneous sutures should be used
will require physician discretion. In our expe-
rience, subcutaneous sutures should be ap-
plied (l) to all full-thickness wounds requiring
obliteration of subcutaneous dead space, (2) to
alleviate wound tension noted during skin clo-
sure, and (3) to enhance skin edge eversion
where necessary (thicker, less pliable skin, e.g.,
forehead, cheek). Even with proper prepara-
tion and subcutaneous suture placement, con-
ventional suturing methods (vertical mattress
sutures) remain the treatment of choice in
areas where marked wound edge eversion is
desired?
Some surgeons may believe that the applica-
tion of subcutaneous sutures provides ade-
quate skin edge eversion and requires only
adhesive strips for epidermal closure. In our
experience, application of adhesive strips will
tend to decrease the degree of skin edge ever-
sion because of the vertical component of
g/
octyl—2-cyanoaciylate leaves a thin layer of polymer on wound. (Below, Icy?) Polymer begins to peel off 7 days after application.
(Below, right) One-year postoperative photograph of healed surgical site with acceptable cosmetic outcome. Arrows point to the
ends of the scar.
Vol
foi
H(
orf
en
he
ad
po
wk
Vol. 102, No. 6 / ocrn.-2-cYANoAc.R\iATE FOR SKIN CLOSURE 2217
FIG. 6. (Lefl) Closure of wound with octyl—2—cyanoac1“ylate without elimination of subcutane-
ous dead space. (Right) Healing and scar contracture results in an inverted scar as overlying skin
retracts into area of dead space.
FIG. 7. (Above, left) Unfavorable bevel of skin edges of wound that would make proper
approximation of epidermis difficult. (Above, right) Application of octyl-2—cyanoacrylate on in-
cision with unfavorable bevel. Note how polymer could enter wound between epidermal skin
edges. (Below) Use of vertical mattress sutures to close incision and evert skin edges in wound
with unfavorable bevel.
force applied by the tape to the skin edge.
However, octyl-2—cyanoacrylate has excellent
mechanical strength and can be used to set the
orientation of the skin edge and hold, or even
enhance, skin edge eversion while the wound is
healing and scar contracture occurs. Another
advantage of octyl-2-cyanoacrylate is that the
polymer provides a waterproof clear dressing,
whereas adhesive strips will fall off when wet.
Despite the superiority of octyl-2-cyanoacrylate
over adhesive strips, neither is as effective as
vertical mattress sutures in enhancing skin
edge eversion. Therefore, sutures should be
used in cases where maximal skin edge ever-
sion is necessary because of nonpliable thick
skin or where unfavorable bevel of the skin
edges exists (Fig. 7). A wound with an unfavor-
able bevel can be converted to a more favor-
Vol. 102, No. 6 / OCTYL-2-CYANOACRYLATE FOR SKIN CLOSURE 4 2217
FIG. 6. (Left) Closure of wound with octyl-2-cyanoacrylate without elimination of subcutane-
ous dead space. (Right) Healing and scar contracture results in an inverted scar as overlying skin
retracts into area of dead space.
FIG. 7. (Above, left) Unfavorable bevel of skin edges of wound that would make proper
approximation of epidermis difficult. (Above, right) Application of octyl-2-cyanoacrylate on in-
cision with unfavorable bevel. Note how polymer could enter wound between epidermal skin
edges. (Below) Use of vertical mattress sutures to close incision and evert skin edges in wound
with unfavorable bevel.
force applied by the tape to the skin edge.
However, octyl-2—cyanoacrylate has excellent
mechanical strength and can be used to set the
orientation of the skin edge and hold, or even
enhance, skin edge eversion while the wound is
healing and scar contracture occurs. Another
advantage of octyl-2-cyanoacrylate is that the
polymer provides a waterproof clear dressing,
whereas adhesive strips will fall off when wet.
Despite the superiority of octyl-2—cyanoacrylate
over adhesive strips, neither is as effective as
vertical mattress sutures in enhancing skin
edge eversion. Therefore, sutures should be
used in cases where maximal skin edge ever-
sion is necessary because of nonpliable thick
skin or where unfavorable bevel of the skin
edges exists (Fig. 7). A wound with an unfavor-
able bevel can be converted to a more favor-
2218
able wound by modifying or reexcising the skin
edge. However, additional skin excision may
not be possible or advisable.
Use of octyl-2-cyanoacrylate has also been
shown to significantly decrease the time re-
quired to close a traumatic or surgical
wound.15’“5 Although many wounds 'may still
need subcutaneous suture; application, the ap-
plication of octyl-2-cyanoacrylate requires sig-
nificantly less time than applying multiple skin
sutures. The larger the wound, the greater the
time savings, as the application time of octyl-2-
cyanoacrylate, unlike that of sutures, does not
increase significantly with incision size. The
reduced time for skin closure resulted in
shorter treatment time and, therefore, less pa-
tient anxiety and decreased cost. Additionally,
patient reaction to the application of the adhe-
sive for skin closure was extremely favorable,
and patients preferred the use of and the final
cosmetic result from the adhesive. Few, if any,
patients required reassurance as to the efficacy
or safety of octyl-2-cyanoacrylate for wound clo-
sure. I
Surgeons must avoid depositing polymer be-
low the level of the skin into the wound. Use of
tissue forceps to aid in skin edge approxima-
tion and eversion while applying the polymer
should be practiced before patient applica-
tions. The best way to avoid subcutaneous dep-
osition of the adhesive is to make sure that the
skin edges are precisely approximated with for-
ceps and/ or everting subcutaneous sutures be-
fore application of octyl-2-cyanoacrylate. If the
material is accidentally deposited below the
level of the epidermis, the polymer will even-
tually extrude through the incision site, similar
to an extruding subcutaneous suture or other
foreign body. In this study, careful use of the
adhesive resulted in the absence of complica-
tions and excellent long-term wound cosmesis.
Wounds that are likely to drain postopera-
tively should not be completely closed with the
polymer because it may inhibit proper wound
drainage. Alternatively, a small region should
remain uncovered or closed with a single su-
ture to allow for drainage. Octyl-2—cyanoacry-
late should not be used in patients that dem-
onstrate any degree of infection, are at risk for
delayed wound healing (diabetics or patients
with collagen vascular diseases), or who have a
history of contact dermatitis. If a seroma or
wound infection should develop, the polymer
can be removed from a small area of the inci-
PLASTIC AND RECONSTRUCTIVE SURGERY, November 1998
sion to allow drainage without wound dehis-
cence.
Octyl-2—cyanoacrylate has several advantages
over previous cyanoacrylate derivatives used as
surgical tissue adhesives. This longer chain cy-
anoacrylate derivative is potentially less tissue
toxic, has an increased three-dimensional
breaking strength,” and is easier to use. Octyl-
2—cyanoacrylate has a plasticizer, which in-
creases the pliability of the polymer, thus, re-
ducing the cracking and early peeling seen
with shorter-chain cyanoacrylate derivatives.
The pliable nature of this product makes it
ideal for use over flexible skin surfaces, such as
the face and neck; Finally, unlike other cyano-
acrylate deratives, octyl-2-cyanoacrylate is
strictly for external use as a skin closure device.
Proper patient selection,‘ meticulous tech-
nique, and limitation to external use will elim-
inate many of the previous problems, noted
when cyanoacrylate derivatives were used in
surgery.
Dean M. Toriumi, M.D.
Division of Facial Plastic and Reconstructive
Surgery,
Department of Otolaryngology—-Head and Neck
Surgery (M/C 648)
Room 2.42
University of Illinois at Chicago
1855 W. Taylor St;
Chicago, Ill. 60612
ACKNOWLEDGMENTS
We wish to thank Kathy Reidy for her assistance in the
‘ execution of the study and Edward L. Applebaum, M.D., for
his help in preparing the manuscript.
This study was partially funded by Closure Medical Cor-
poration, Raleigh, Nv.C.
REFERENCES
1. Borges, A. F. Elective Incision: and Scar Revision. Boston:
Little, Brown, 1973.
2. Davidson, T. M. Subcutaneous suture placement. La-
ryngoscope 97: 501, 1987.
3. Reiter, D. Methods and materials for wound closure.
Ololaryngol. Clin. North Am. 285: 1069, 1995.
4. Kamer, F. M., and Joseph, J. H. Histoacryl: Its use in
aesthetic facial plastic surgery. Arch. Otolaryngol. Head
Neck Surg. 115: 193, 1989.
5. Ellis, D. A. F., and Shaikh, A. The ideal tissue adhesive
in facial plastic and reconstructive surgery. ]. 0tolar—
yngol. 19: 68, 1990.
6. Quinn,_]. V., Drzewiecki, A. E., Li, M. M., et al. A ran-
domized, controlled trial comparing a tissue adhesive
with suturing in the repair of pediatric facial lacera-
tions. Ann. Emerg. Med. 22: 1130, 1993.
Vol. 102, No. 6 / oCrvL-2-CIANOACRYIATE FOR SKIN CLOSURE
7.
10.
11.
12.
13.
Alhopuro, S., Rintala, A., Salo, N., et al. Tissue adhesive
versus sutures in closure of incision wounds. Ann. Chir.
Gynacol. 65: 308, 1976.
. Ronis, M. L., Harwick,]. D., Fung, R., et al. Review of
cyanoacrylate glues with emphasis on their otorhino-
laryngological applications. Laryngoscope 94: 210, 1984.
. Tse, D. T., Panje, W. R., and Anderson, R. L. Cyanoac-
rylate adhesive to stop CSF leaks during orbital sur-
gery. Arch. Ophthalinol. 102: 1337, 1984.
Vinters, H. V., Lundie, M. J., and Kaufmann, C. E.
Long term pathological follow-up of cerebral arterio-
venous malformations treated by embolization.
N. Engl.]. Med. 314: 477, 1974.
Leonard, F., Kulkarni, R. K., Brandes, G., et al. Synthesis 1
and degradation of poly(alkyl alpha-cyanoacrylates).
]. Appl. Polymer Sci. 10: 259, 1966.
Toriumi, D. M., Raslan, W. F., Friedman, M., et al. His-
totoxicity of cyanoacylate tissue adhesives: A compar-
ative study. Arch. Otolaryngol. Head Neck Surg. 116: 546,
1990.
Toriumi, D. M., Raslan, W. F., Friedman, M., et al. Vari-
14
15
16
17
18
2219
able histotoxicity of Histoacryl when used in a subcu-
taneous site: An experimental study. Laryngoscope101:
339, 1991.
. Perry, L. C. An Evaluation of Acute Incisional Strength with
Traumaseal Surgical Tissu.e.Adhesive Wound Closure. Leo-
nia, N.].: Dimensional Analysis Systems, 1995. 2
. Q_uinn,_]., Wells, G., Sutcliffe, T., et al. A randomized
trial comparing octylcyanoacrylate tissue adhesive and
sutures in the management of lacerations. ].A.M.A.
277: 1527, 1997. ‘
. Maw,_]. L., Q_uinn,]. V., Wells, G. A., et al. A prospective
comparison of octylcyanoacrylate tissue adhesive and
suture for the closure of head and neck incisions. ].
Otolaryngol. 26: 26, 1997.
. Hollander,]. E., Singer, A.].,Valantine,S., et al. Wound
registry: Development and validation. Ann. Emerg.
Med. 25: 675, 1995.
. Quinn, ]. V., Drzewiecki, A. E., Stiell, I. G., et al. Ap-
pearance scales to measure the cosmetic outcomes of
healed lacerations. Am]. Emerg. Med. 13: 229, 1995.